FierceBiotech18 天
Qlaris sees double as drug reduces eye pressure in pair of phase 2 trials
The drug in question, dubbed QLS‑111, has been created with Qlaris’ ATP-sensitive potassium channel modulator platform and is designed to lower intraocular pressure (IOP). The results ...